Video

Practical Implementation of Non-Steroidal Mineralocorticoid Receptor Antagonists to Reduce Cardiorenal Risk

Published: 18 Feb 2025

  • Views:

    Views Icon 33

  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

As part of e-SPACE Cardio-Renal-Metabolic 2024, Dr Muthiah Vaduganathan and Dr David Charytan discuss the practical implementation of non-steroidal mineralocorticoid receptor antagonists to reduce cardiorenal risk.

e-SPACE Cardio-Renal-Metabolic 2024 would like to thank the following sponsors:

Comments

You must be to comment. If you are not registered, you can register here.